MAPK11 plays a role in a variety of female tumors (breast cancer (He et al., 2014), uterine endometrial cancer (Li et al., 2019), cervical cancer, ovarian cancer, and uterine carcinosarcoma), and its expression levels are significantly reduced (Katopodis et al., 2021). This evidence concerns the gene MAPK11 and uterine carcinosarcoma.